Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Delanaye

Showing results (21-30 of 346) with videos related to

Pageof 35
Sort By:
Revue Medicale De Liege|January 16, 2025
[Patient with type 2 diabetes and progressive chronic kidney disease]André Scheen, Pierre Delanaye
Kidney International Reports|January 11, 2021
Adherence to Therapy: Burden, Complexity, and PerceptionPierre Delanaye, Christophe Mariat
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 3, 2009
Defining a "reference population": no easy taskEtienne Cavalier, Pierre Delanaye
Kidney International Reports|October 26, 2020
The Authors ReplyPierre Delanaye, Hans Pottel
Lancet (London, England)|September 28, 2010
Effects of fibrates on cardiovascular outcomesPierre Delanaye, André J Scheen
Revue Medicale Suisse|August 25, 2021
[SGLT2 inhibitors: focus on kidneys and nephroprotection]André J Scheen, Pierre Delanaye
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 6, 2005
Massive renal and adrenal calcifications in a young dialysis patient with familial Mediterranean feverPierre Delanaye, Jean Marie Krzesinski
Kidney International|October 31, 2020
How to interpret an estimated glomerular filtration rate (eGFR) in 2020?Marc De Broe, Pierre Delanaye
Diabetes Care|March 22, 2014
Comment on Tsuda et al. Poor glycemic control is a major factor in the overestimation of glomerular filtration rate in diabetic patients. Diabetes care 2014;37:596-603Pierre Delanaye, André J Scheen
Nature Reviews. Nephrology|March 13, 2025
A difficult path to point-of-care measurement of glomerular filtration ratePierre Delanaye, Richard J Glassock
Pageof 35

Showing results (21-30 of 346) with videos related to

Sort By:
Pageof 35
Revue Medicale De Liege|January 16, 2025
[Patient with type 2 diabetes and progressive chronic kidney disease]André Scheen, Pierre Delanaye
Kidney International Reports|January 11, 2021
Adherence to Therapy: Burden, Complexity, and PerceptionPierre Delanaye, Christophe Mariat
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 3, 2009
Defining a "reference population": no easy taskEtienne Cavalier, Pierre Delanaye
Kidney International Reports|October 26, 2020
The Authors ReplyPierre Delanaye, Hans Pottel
Lancet (London, England)|September 28, 2010
Effects of fibrates on cardiovascular outcomesPierre Delanaye, André J Scheen
Revue Medicale Suisse|August 25, 2021
[SGLT2 inhibitors: focus on kidneys and nephroprotection]André J Scheen, Pierre Delanaye
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 6, 2005
Massive renal and adrenal calcifications in a young dialysis patient with familial Mediterranean feverPierre Delanaye, Jean Marie Krzesinski
Kidney International|October 31, 2020
How to interpret an estimated glomerular filtration rate (eGFR) in 2020?Marc De Broe, Pierre Delanaye
Diabetes Care|March 22, 2014
Comment on Tsuda et al. Poor glycemic control is a major factor in the overestimation of glomerular filtration rate in diabetic patients. Diabetes care 2014;37:596-603Pierre Delanaye, André J Scheen
Nature Reviews. Nephrology|March 13, 2025
A difficult path to point-of-care measurement of glomerular filtration ratePierre Delanaye, Richard J Glassock
Pageof 35